HL7 Terminology (THO)
5.4.0 - Continuous Process Integration (ci build) International flag

HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 5.4.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions

ValueSet: Drug Entity (Experimental)

Official URL: http://terminology.hl7.org/ValueSet/v3-DrugEntity Version: 2.0.0
Active as of 2022-10-11 Responsible: Health Level Seven International Computable Name: DrugEntity
Other Identifiers: urn:ietf:rfc:3986#Uniform Resource Identifier (URI)#urn:oid:2.16.840.1.113883.11.21013

Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license

A value representing the specific kind of Drug Entity the instance represents.

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

 

Expansion

Expansion based on codesystem EntityCode v3.0.0 (CodeSystem)

This value set contains 4 concepts.

LevelCodeSystemDisplayInactiveDefinition
1  _DrugEntityhttp://terminology.hl7.org/CodeSystem/v3-EntityCodeDrugEntityinactive

A substance whose therapeutic effect is produced by chemical action within the body.

2    _ClinicalDrughttp://terminology.hl7.org/CodeSystem/v3-EntityCodeClinicalDruginactive

Any substance or mixture of substances manufactured, sold or represented for use in: (a) the diagnosis, treatment, mitigation or prevention of a disease, disorder, abnormal physical state, or its symptoms, in human beings or animals; (b) restoring, correcting or modifying organic functions in human beings or animals.

3      _ActiveIngredientDrugEntityTypehttp://terminology.hl7.org/CodeSystem/v3-EntityCodeActiveIngredientDrugEntityTypeinactive

Any substance which, when combined with other ingredients, delivers all or part of the therapeutic benefit associated with a medication.

3      _ManufacturedDrughttp://terminology.hl7.org/CodeSystem/v3-EntityCodeManufacturedDruginactive

Identifies a drug or the use of a drug as produced by a specific manufacturer


Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionCustodianAuthorComment
2023-11-14reviseTSMGMarc DuteauAdd standard copyright and contact to internal content; up-476
2022-10-21createSDMarc DuteauAdd missing value sets for cda-core-2.0; up-116